More positive newsflow for probiotics brand $BIO in both Canada and Australia.
ASX Announcement
Hightlights
● Following a successful test market launch in Canada, Biome moves to an official market launch in both health retail and practitioner markets
● First Canadian staff member to start on the road (in Ontario) this November
● Three additional products approved by Health Canada in October
● Biome reaches a new three month record with 188,000 consumer units purchased of Activated Probiotics in Australian market, up ~60% vs PCP (Aug-Oct 2023)
● Terry White Chemmart retail scan sales reach $3.5m for 12 months to October up ~75%
● Biome Cholesterol Probiotic successfully launched internationally
My Assessment
Good news all round.
Sales appear to be running ahead of the 50% my model requires for $BIO to hit the 2027 Strategic goals.
The test maketing period in Canada was shorter than I had in mind (no good reason), so the full commercial rollout with 12/17 products approved will start to get acoounts going this year. While the FY25 contribution to sales will be small, it sets things up nicely for FY26 and beyond. BVN has spoken very positively about the Canadian market in his last presentation, which as I recall was delivered while he was in Canada. A leading indicator of market traction will be indicated by the rate at which BVN adds further "educational" staff.
Overall, good news.
I'm happy to keep at my current RL position which is 2%, as I still see this as a higher risk proposition and will build my position over time.
Disc: Held in RL and SM